Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023

SELL
$0.22 - $31640.0 $3,059 - $440 Million
-13,907 Reduced 99.72%
39 $0
Q3 2022

Nov 10, 2022

BUY
$1.04 - $34160.0 $12,377 - $407 Million
11,901 Added 581.96%
13,946 $15,000
Q2 2022

Aug 10, 2022

SELL
$1.11 - $2.99 $2,701 - $7,277
-2,434 Reduced 54.34%
2,045 $3,000
Q1 2022

May 16, 2022

BUY
$1.93 - $10.75 $8,434 - $46,977
4,370 Added 4009.17%
4,479 $9,000
Q4 2021

Feb 14, 2022

BUY
$9.1 - $12.62 $991 - $1,375
109 New
109 $1,000

Others Institutions Holding ALLR

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About Allarity Therapeutics, Inc.


  • Ticker ALLR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 10,260,200
  • Market Cap $10.4M
  • Description
  • Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is in Phase 2 clinical trials for ovarian cancer; D...
More about ALLR
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.